Pathological findings in explanted prosthetic heart valves from ventricular assist devices

References

• Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics—2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: 85–151
   PubMed Web of Science ®Google Scholar
• Delgado D H, Rao V, Ross H J, Verma S, Smedira N G. Mechanical circulatory assistance: state of art. Circulation 2002; 106: 2046–2050
   PubMed Web of Science ®Google Scholar
• Rose E A, Gelijns A C, Moskowitz A J, et al. Long-term left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345: 1435–1443
   PubMed Web of Science ®Google Scholar
• Marcel R, Meyer D M. An overview of approved and investigational left ventricular assist devices. BUMC Proc 2004; 17: 407–410
   Google Scholar
• El-Banayosy A, Korfwr R, Morshuis M, et al. Bridging to cardiac transplantation with the Thoratec ventricular assist device. Thorac Cardiovasc Surg 1999; 47(Suppl 2)307–310
   PubMed Web of Science ®Google Scholar
• Zafeiridis A, Jeevanandam V, Houser S R, et al. Regression of cellular hypertrophy after ventricular assist device support. Circulation 1998; 98: 656–662
   PubMed Web of Science ®Google Scholar
• Levin H R, Oz M C, Chen J M, Packer M, Rose E A, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995; 91: 2717–2720
   PubMed Web of Science ®Google Scholar
• Ishihara T, Ferrans V J, Boyce S W, Jones M, Roberts W C. Structure and classification of cuspal tears and perforations in porcine bioprosthetic cardiac valves implanted in patients. Am J Cardiol 1981; 48: 665–678
   PubMed Web of Science ®Google Scholar
• Lietz K, Miller L W. Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future?. Curr Opin Cardiol 2005; 20: 132–137
   PubMed Web of Science ®Google Scholar
• Lietz K, Miller L W. Left ventricular assist devices: evolving devices and indications for use in ischemic heart disease. Curr Opin Cardiol 2004; 19: 613–618
   PubMed Web of Science ®Google Scholar
• Moazami N, Argenziano M, Kohomoto T, et al. Inflow valve regurgitation during left ventricular assist device support may interfere with reverse ventricular remodeling. Ann Thorac Surg 1998; 65: 628–631
   PubMed Web of Science ®Google Scholar
• Birks E J, Tansley P D, Yacoub M H, et al. Incidence and clinical management of life threatening left ventricular assist device failure. J Heart Lung Transplant 2004; 23: 964–969
   PubMed Web of Science ®Google Scholar
• Morgan J A, John R, Rao V, et al. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg 2004; 127: 1309–1316
   PubMed Web of Science ®Google Scholar
• Goubergrits L, Affeld K, Kertzscher U. Innovative developments of the heart valves designed for use in ventricular assist devices. Expert Rev Med Devices 2005; 2: 61–71
   PubMed Web of Science ®Google Scholar
• Butany J, Leask R. The failure modes of biological prosthetic heart valves. J Long Term Eff Med Implants 2001; 11: 115–135
   PubMedGoogle Scholar
• Grabenwoger M, Grimm M, Eybl E, et al. New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. J Thorac Cardiovasc Surg 1992; 104: 14–21
   PubMed Web of Science ®Google Scholar
• Nistal F, Garcia-Martinez V, Fernandez D, et al. Degenerative pathologic findings after long-term implantation of bovine pericardial bioprosthetic heart valves. J Thorac Cardiovasc Surg 1988; 96: 642–651
   PubMed Web of Science ®Google Scholar
• Sacks M S, Schoen F J. Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res 2002; 62: 359–371
   PubMed Web of Science ®Google Scholar
• Ferrans V J, Spray T L, Billingham M E, Roberts W C. Ultrastructure of Hancock porcine valvular heterografts. Pre- and post-implantation changes. Circulation 1978; 58: 110–118
   Web of Science ®Google Scholar
• Moczar M, Houel R, Ginat M, Clerin V, Wheeldon D, Loisance D. Structural changes in porcine bioprosthetic valves of a left ventricular assist system in human patients. J Heart Valve Dis 2000; 9: 88–95
   PubMed Web of Science ®Google Scholar
• Wilhelmi M H, Mertsching H, Wilhelmi M, Leyh R, Haverich A. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis 2003; 12: 520–526
   PubMed Web of Science ®Google Scholar
• Human P, Zilla P. Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration?. J Long Term Eff Med Implants 2001; 11: 199–220
   PubMedGoogle Scholar
• Jegatheeswaran A, Butany J. Pathology of infectious and inflammatory diseases in prosthetic heart valves. Cardiovasc Pathol 2006; 15: 252–255
   PubMed Web of Science ®Google Scholar
• Butany J, Zhou T, Leong S W, et al. Inflammation and infection in nine surgically explanted Medtronic Freestyle stentless aortic valves. Cardiovasc Pathol 2007; 16: 257
   PubMed Web of Science ®Google Scholar
• Moore M A, Adams A K. Calcification resistance, biostability, and low immunogenic potential of porcine heart valves modified by dye-mediated photooxidation. J Biomed Mater Res 2001; 56: 24–30
   PubMed Web of Science ®Google Scholar